We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byMegan Adams
Modified over 2 years ago
Cardiovascular effects of anti-hyperglycemic therapy Edoardo Mannucci Diabetes Agency Careggi teaching hospital, Firenze, Italy
MACE CV mort.
Effects of intensified glycemic control on CV mortality
MYOCARDIAL ISCHEMIA Adrenercic activation could have a negative impact on the prognosis of
Secondary prevention of macrovascular events in patients with type 2 diabetes: The PROACTIVE Study Dormandy JA et al., Lancet 2005; 366: 1279
Relative risk SU vs other therapies vs. Conventional vs. Insulin vs. Metformin Mortality MI Stroke
Effect of SU on MACE Monami M, Ganovese S, Mannucci E – 2013 [in press]
Effect of SU on mortality Monami M, Ganovese S, Mannucci E – 2013 [in press]
Prof. Khalifa M. Abdallah Professor of Internal Medicine Unit of Diabetes & Metabolic Diseases Alexandria Faculty of Medicine Importance of early glycemic.
Peripheral Arterial Disease Mehul Bhatt, MD Interventional Cardiology / Vascular Medicine Athens Heart Center.
1 What do we know about access to chronic disease medicines ? Dr Shanthi Mendis Coordinator Chronic Diseases Prevention and Management Department of Chronic.
Limitations and opportunities of insulin therapy Luigi Meneghini June 8 th, 2012.
Insulin Therapy in Type 2 Diabetes: Current and Future Directions.
Optimum Care in Type 2 Diabetes: Does One Size Fit All? James LaSalle on behalf of the Global Partnership for Effective Diabetes Management This slideset.
Statin Landmark Trials Across the Spectrum of Risk: Secondary CV Prevention.
EARLY COMBINATION THERAPY IN DIABETES MELLITUS:EFFECT ON LONG TERM CONTROL Dr. SANJAY KALRA Bharti Hospital,Karnal.
Progress in Vascular Anesthesiology Donald M. Voltz, M.D. Assistant Professor of Anesthesiology Case Western Reserve University/University Hospitals of.
Diabetes in Young Women Francine R. Kaufman, M.D. Professor of Pediatrics The Keck School of Medicine of USC Head, Center for Diabetes and Endocrinology.
Hypoglycemia in Diabetes: the limiting factor to optimal control June 7, 2012 Kenneth Cusi, MD, FACP, FACE Professor of Medicine Chief, Division of Endocrinology,
Tight Glycemic Control: How Sweet It Is! Virginia Point of Care Coordinators April 22, 2005.
Where we stand in diabetes field ? Prof. Ibrahim El-Ebrashy Cairo University Director NIDE.
Diabetic Nephropathy in T2DM: Blood Pressure and Cholesterol Targets Nemanja Stojanović Consultant Endocrinologist Queens Hospital, Romford.
Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.
Manuel Battegay Div. Infectious Diseases & Hospital Epidemiology HIV complications and morbidity.
Things we knew, things we did… Things we have learnt, things we should do LIPID MANAGEMENT IN PRIMARY CARE: HOW WELL DO WE DO? Dr. Carlos Brotons Research.
Program Editors Ralph Anthony DeFronzo, MD Professor of Medicine and Chief of the Diabetes Division University of Texas Health Science Center Audie L.
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels Frank M. Sacks, M.D., Marc A. Pfeffer,
Achieving A1C and Glycemic Targets with Insulin What to Do When Oral Agents Fail New Paradigms, Guidelines, and Evolving Strategies JUAN P. FRIAS, M.D.,
Life Underwriting Insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA (not licensed in New York) and John.
ASA - Is there a Primary Prevent Indication in Diabetes? Contemporary Therapeutic Issues in Cardiovascular Disease Saturday, May 8 th, 2010 Patrick Robertson,
Cardiovascular Side Effects of HIV Treatment Jean-Guy Baril, MD Mark Wainberg, Phd.
Type II Diabetes Gil C. Grimes, MD Assistant Professor Community and Family Medicine Scott and White Memorial Hospital September 2007.
Achieving Good Glycemic Control. Aim Provide practical guidance on improving diabetes care through highlighting the need to: treat to glucose targets.
Diabetic Medication Update Gil C. Grimes, MD April 2007.
The Power of Behavioural Change and the Role of Cognitions in symptom severity and disability: Research Questions What treatments are effective for symptoms.
All About Strokes Allan L Bernstein MD Neurology.
Insulin initiation made safer and simpler (Premix analogue)
CDA Clinical Practice Guidelines J. Robin Conway M.D. Diabetes Clinic Smiths Falls, ON
© 2016 SlidePlayer.com Inc. All rights reserved.